US$ 20.60
retatrutide vs semaglutide vs tirzepatide vs. Semaglutide: Key Differences & Benefits Retatrutide vs. Other Weight Loss
Description
The main types of therapy shown to reduce binge eating symptoms are cognitive behavioral therapy for eating disorders (CBT-E), interpersonal psychotherapy, and dialectical behavior therapy (DBT)

semaglutide users received 1.0 mg (49%), while 35% and 16% received 0.25 mg and 0.5 mg, respectively

The first Phase 3 trial to report results, TRIUMPH-4, was published on 11 December 2025

Tirzepatide, a newer GLP-1/GIP receptor agonist, activates two separate appetite pathways rather than one, making it effective for patients who've stopped responding to single-agent GLP-1 therapy

We understand that shifts in energy, blood sugar, or appetite can affect a persons mood

According to NICE guideline NG28 on type 2 diabetes management and the specific NICE Technology Appraisal for tirzepatide, GLP-1 receptor agonists like Mounjaro may be considered as part of a comprehensive treatment strategy when glycaemic targets are not achieved with other therapies or when weight loss would provide significant clinical benefit